From: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
Pathological characteristic | No. | MIIP expression, n (%) | χ 2 | P | |
---|---|---|---|---|---|
Low | High | ||||
Histologic subtype | |||||
Endometrioid | 183 | 126 (68.85) | 57 (31.15) | 1.827 | 0.176 |
Non-endometrioid | 22 | 12 (54.55) | 10 (45.45) | ||
Histopathological grade | |||||
1 | 82 | 58 (70.73) | 24 (29.27) | 0.204 | 0.903 |
2 | 77 | 55 (71.43) | 22 (28.57) | ||
3 | 24 | 16 (66.67) | 8 (22.33) | ||
FIGO stage | |||||
I and II | 166 | 109 (65.77) | 57 (34.33) | 6.930 | 0.008 |
III and IV | 39 | 34 (87.28) | 5 (12.82) | ||
Myometrial invasion | |||||
<1/2 | 141 | 90 (63.83) | 51 (36.17) | 7.519 | 0.006 |
≥1/2 | 64 | 53 (82.01) | 11 (17.19) | ||
Lymph node status | |||||
Negative | 179 | 110 (61.45) | 69 (38.55) | 5.312 | 0.021 |
Positive | 26 | 22 (84.62) | 4 (15.38) |